ArticleJournal of veterinary internal medicine2026
Subcutaneous ureteral bypass explantation in 21 cats (2015-2023): outcomes and owner perceptions.
Article in Journal of veterinary internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubcutaneous ureteral bypass (SUB) can be an effective treatment for ureteral obstruction in cats, but SUB explantation is little documented. HYPOTHESIS/
objectivesDescribe reasons for SUB explantation, outcomes, and owner experiences. We hypothesized that explantation would be effective in managing common SUB-related complications. ANIMALS: Twenty-one cats (31 SUBs) that underwent 29 explantations.
methodsRetrospective case-series of cats undergoing explantation between 2015 and 2023 with medical record review and 20 owners emailed for follow-up. Results are median (range).
resultsExplantation was performed 1.8 years (0.2-4.1 years) after placement because of positive urine culture (PUC; 15/21), SUB obstruction (8/21), sterile cystitis (4/21), and suspected SUB failure (2/21). Twenty-six out of 31 ureters had documented patency. Seventeen cats had all implants removed (9 unilateral, 8 bilateral). Two underwent unilateral explantation and ipsilateral ureteronephrectomy. Two with bilateral SUBs underwent unilateral explantation. Follow-up after explantation was 596 days (3-2310 days). Four cats had ureteral re-obstruction (1 after partial obstruction at explantation), 10 did not re-obstruct and the remainder were undetermined. Seven cats died at 614 days (405-2200 days), 11 were lost to follow-up at 135 days (19-1774 days) after explantation, and 3 remained alive. Four deaths were renal related (2/4 re-obstructions). Nine of 15 cats explanted due to PUC had a negative postoperative urine culture. Three of 15 cats had clinical signs related to PUC postoperatively. Questionnaire response was 9 of 20, and 8 of 9 owners would consider explantation if in the same situation again. CONCLUSIONS AND CLINICAL IMPORTANCE: For SUB cats with complications, explantation is a viable option. A small proportion of cats had clinical signs of PUC, or ureteral re-obstruction postoperatively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.